Tirzepatide reduces obstructive sleep apnea symptoms and associated risks
1. In this randomized controlled trial, in patients with both moderate-severe obstructive sleep apnea (OSA) and obesity, it was found ...
Tag: Tirzepatide
#VisualAbstract: Tirzepatide Improved Outcomes in Patients with Obstructive Sleep Apnea and Obesity
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
#VisualAbstract: Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Liver Fibrosis was More Effective Than Placebo at Resolving MASH
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be ...
Eli Lilly: Tirzepatide Shows Promise In Treating Obstructive Sleep Apnea In Two Phase 3 Clinical Trials
Tirzepatide led to a 63% mean reduction in restricted/obstructed breathing events per hour in patients with moderate to severe obstructive ...
#VisualAbstract: Once-weekly tirzepatide significantly improves weight and glycemic control in patients with with obesity and type 2 diabetes
Click to read the study in The Lancet ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Once-weekly tirzepatide significantly improves weight and glycemic control in patients with with obesity and type 2 diabetes
1. Body weight reduction at week 72 was significantly greater with tirzepatide versus placebo. 2. Hemoglobin A1c was significantly reduced ...
Tirzepatide reduces body weight and improves cardiometabolic function in patients with obesity
1. Tirzepatide treatment significantly reduced body weight and fat composition in obese patients while improving cardiometabolic risk factors and physical ...
#VisualAbstract: Tirzepatide Once Weekly for the Treatment of Obesity
Click here to read this study in the New England Journal of Medicine.
Supplementation of tirzepatide for type 2 diabetics on basal insulin improved glycemic control compared to placebo
1. This randomized controlled trial demonstrated that in adult type 2 diabetes patients on daily basal insulin, adding tirzepatide significantly ...
Tirzepatide is superior to insulin glargine for management of type 2 diabetes and elevated cardiovascular risk
1. From baseline to 52 weeks, tirzepatide resulted in a greater reduction in mean HbA1c levels compared to insulin glargine. ...